These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 11108692)
41. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). Smith SC; Dove JT; Jacobs AK; Kennedy JW; Kereiakes D; Kern MJ; Kuntz RE; Popma JJ; Schaff HV; Williams DO; Gibbons RJ; Alpert JP; Eagle KA; Faxon DP; Fuster V; Gardner TJ; Gregoratos G; Russell RO; Smith SC; ; J Am Coll Cardiol; 2001 Jun; 37(8):2215-39. PubMed ID: 11419905 [No Abstract] [Full Text] [Related]
42. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. Stone GW; Bertrand ME; Moses JW; Ohman EM; Lincoff AM; Ware JH; Pocock SJ; McLaurin BT; Cox DA; Jafar MZ; Chandna H; Hartmann F; Leisch F; Strasser RH; Desaga M; Stuckey TD; Zelman RB; Lieber IH; Cohen DJ; Mehran R; White HD; JAMA; 2007 Feb; 297(6):591-602. PubMed ID: 17299194 [TBL] [Abstract][Full Text] [Related]
43. Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy). Breeman A; Mercado N; Lenzen M; van den Brand MM; Harrington RA; Califf RM; Topol EJ; Simoons ML; Boersma E; Cardiology; 2002; 98(4):195-201. PubMed ID: 12566649 [TBL] [Abstract][Full Text] [Related]
44. [Glycoprotein IIb/IIIa antagonists]. Hennemann A Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193 [No Abstract] [Full Text] [Related]
46. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention. Ronner E; Dykun Y; van den Brand MJ; van der Wieken LR; Simoons ML Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912 [No Abstract] [Full Text] [Related]
47. Therapeutic adjuncts for immediate transfer to the catheterization laboratory in patients with acute coronary syndromes. Kereiakes DJ; Young J; Broderick TM; Shimshak TM; Abbottsmith CW Am J Cardiol; 2000 Dec; 86(12B):10M-17M. PubMed ID: 11206013 [TBL] [Abstract][Full Text] [Related]
49. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Mehta SR; J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860 [TBL] [Abstract][Full Text] [Related]
50. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. Morrow DA; Cannon CP; Rifai N; Frey MJ; Vicari R; Lakkis N; Robertson DH; Hille DA; DeLucca PT; DiBattiste PM; Demopoulos LA; Weintraub WS; Braunwald E; JAMA; 2001 Nov; 286(19):2405-12. PubMed ID: 11712935 [TBL] [Abstract][Full Text] [Related]
54. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Braunwald E; Antman EM; Beasley JW; Califf RM; Cheitlin MD; Hochman JS; Jones RH; Kereiakes D; Kupersmith J; Levin TN; Pepine CJ; Schaeffer JW; Smith EE; Steward DE; Theroux P; Gibbons RJ; Alpert JS; Eagle KA; Faxon DP; Fuster V; Gardner TJ; Gregoratos G; Russell RO; Smith SC Circulation; 2000 Sep; 102(10):1193-209. PubMed ID: 10973852 [No Abstract] [Full Text] [Related]
55. A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes. Topol EJ J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):S123-9. PubMed ID: 12644350 [TBL] [Abstract][Full Text] [Related]
56. Glycoprotein IIb/IIIa receptor inhibitor use in unstable angina/non-ST-segment elevation myocardial infarction: an appropriate-use model for the emergency department. Hoekstra J J Emerg Med; 2000 Oct; 19(3 Suppl):13S-19S. PubMed ID: 11050379 [TBL] [Abstract][Full Text] [Related]
57. [Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists]. Araujo R; Agustí A Med Clin (Barc); 2000 Oct; 115(11):435-7. PubMed ID: 11093849 [No Abstract] [Full Text] [Related]
58. Efficacy of low-molecular-weight heparin in acute coronary syndromes. Wallentin L Am Heart J; 2000 Feb; 139(2 Pt 2):S29-32. PubMed ID: 10650313 [No Abstract] [Full Text] [Related]
59. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697 [TBL] [Abstract][Full Text] [Related]
60. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Labinaz M; Kilaru R; Pieper K; Marso SP; Kitt MM; Simoons ML; Califf RM; Topol EJ; Armstrong PW; Harrington RA Circulation; 2002 Jan; 105(3):322-7. PubMed ID: 11804987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]